Diaphorina citri psyllid: psy2035

Annotation transfered from Closely Related SWISS-PROT Entries

No confident close homologs for annotation transfering were detected in SWISSPROT

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0008201 [MF]	heparin binding	probable	GO:0043168, GO:1901681, GO:0097367, GO:0043167, GO:0005539, GO:0003674, GO:0005488
GO:0009897 [CC]	external side of plasma membrane	probable	GO:0009986, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0018149 [BP]	peptide cross-linking	probable	GO:0044267, GO:0044260, GO:0044238, GO:0019538, GO:0009987, GO:0006464, GO:0043170, GO:0071704, GO:0043412, GO:0036211, GO:0008150, GO:0044237, GO:0008152
GO:2000379 [BP]	positive regulation of reactive oxygen species metabolic process	probable	GO:0009893, GO:0019222, GO:0031325, GO:0031323, GO:2000377, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0007050 [BP]	cell cycle arrest	probable	GO:0044699, GO:0045786, GO:0051726, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0022402, GO:0048523, GO:0048519, GO:0044763, GO:0050789, GO:0007049
GO:0051128 [BP]	regulation of cellular component organization	probable	GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0050431 [MF]	transforming growth factor beta binding	probable	GO:0019955, GO:0003674, GO:0019838, GO:0005515, GO:0005488
GO:0016525 [BP]	negative regulation of angiogenesis	probable	GO:0051093, GO:0022603, GO:0050793, GO:0045765, GO:0008150, GO:1901342, GO:0065007, GO:2000026, GO:0051239, GO:0048519, GO:0050789
GO:0070062 [CC]	extracellular vesicular exosome	probable	GO:0043230, GO:0031982, GO:0044421, GO:0065010, GO:0031988, GO:0005575, GO:0005576, GO:0043227, GO:0043226
GO:0010751 [BP]	negative regulation of nitric oxide mediated signal transduction	probable	GO:0009968, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010749, GO:0023051, GO:0048519, GO:0010646, GO:0050789, GO:0048523, GO:0010648
GO:0043236 [MF]	laminin binding	probable	GO:0003674, GO:0005488, GO:0005515, GO:0050840
GO:0005927 [CC]	muscle tendon junction	probable	GO:0070161, GO:0005575, GO:0005912, GO:0005924, GO:0030054, GO:0030055
GO:0002605 [BP]	negative regulation of dendritic cell antigen processing and presentation	probable	GO:0002578, GO:0002577, GO:0008150, GO:0065007, GO:0002682, GO:0002683, GO:0048519, GO:0002604, GO:0050789
GO:2000462 [BP]	positive regulation of eukaryotic cell surface binding	probable
GO:0009887 [BP]	organ morphogenesis	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0070052 [MF]	collagen V binding	probable	GO:0005518, GO:0003674, GO:0005488, GO:0005515
GO:0070051 [MF]	fibrinogen binding	probable	GO:0032403, GO:0003674, GO:0005488, GO:0005515
GO:0043154 [BP]	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	probable	GO:0019222, GO:0007569, GO:0010941, GO:0042981, GO:0050789, GO:0044699, GO:0051346, GO:2000116, GO:2000117, GO:0043086, GO:0043067, GO:0010466, GO:0065007, GO:0044092, GO:0043281, GO:0065009, GO:0010259, GO:0006915, GO:0052547, GO:0052548, GO:0009987, GO:0050794, GO:0012501, GO:0044763, GO:0010951, GO:0051336, GO:0050790, GO:0008150
GO:0031091 [CC]	platelet alpha granule	probable	GO:0005737, GO:0043231, GO:0016023, GO:0030141, GO:0044464, GO:0044444, GO:0005623, GO:0031988, GO:0005575, GO:0043229, GO:0031410, GO:0044424, GO:0005622, GO:0043227, GO:0043226, GO:0031982
GO:0010763 [BP]	positive regulation of fibroblast migration	probable	GO:0051272, GO:0030335, GO:0030334, GO:0040017, GO:0040012, GO:0008150, GO:0048518, GO:0051270, GO:2000145, GO:2000147, GO:0010762, GO:0065007, GO:0032879, GO:0050794, GO:0050789, GO:0048522
GO:0001786 [MF]	phosphatidylserine binding	probable	GO:0043168, GO:0072341, GO:0005543, GO:0031406, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0016597
GO:0010757 [BP]	negative regulation of plasminogen activation	probable	GO:0051248, GO:0070613, GO:0010605, GO:0080090, GO:0019222, GO:0060255, GO:0051246, GO:0050789, GO:0008150, GO:0065007, GO:0010755, GO:0048519, GO:0009892, GO:0010955, GO:0010468
GO:0010811 [BP]	positive regulation of cell-substrate adhesion	probable	GO:0045785, GO:0010810, GO:0030155, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0010754 [BP]	negative regulation of cGMP-mediated signaling	probable	GO:0009968, GO:0023057, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0010752, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0017134 [MF]	fibroblast growth factor binding	probable	GO:0003674, GO:0019838, GO:0005515, GO:0005488
GO:0005604 [CC]	basement membrane	probable	GO:0005578, GO:0031012, GO:0005575, GO:0005576, GO:0044420, GO:0044421
GO:0009749 [BP]	response to glucose stimulus	probable	GO:0009746, GO:1901700, GO:0009743, GO:0034284, GO:0050896, GO:0008150, GO:0042221, GO:0010033
GO:0032026 [BP]	response to magnesium ion	probable	GO:0042221, GO:0050896, GO:0010035, GO:0008150, GO:0010038
GO:0042535 [BP]	positive regulation of tumor necrosis factor biosynthetic process	probable	GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:0031323, GO:0042035, GO:0050789, GO:0080090, GO:0010604, GO:0032680, GO:0042534, GO:0009891, GO:0051246, GO:0051247, GO:0065007, GO:0048518, GO:0042108, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0051239, GO:0001817, GO:0010557, GO:0010556, GO:0048522
GO:0043537 [BP]	negative regulation of blood vessel endothelial cell migration	probable	GO:0030336, GO:0040013, GO:0030334, GO:0010594, GO:0010632, GO:0010633, GO:0010596, GO:0051271, GO:0040012, GO:0065007, GO:0043535, GO:0051270, GO:2000145, GO:0008150, GO:0051239, GO:2000146, GO:0048519, GO:0032879, GO:0050794, GO:0050789, GO:0048523
GO:0043536 [BP]	positive regulation of blood vessel endothelial cell migration	probable	GO:0010634, GO:0051272, GO:0030335, GO:0030334, GO:0010595, GO:0010594, GO:0010632, GO:0040017, GO:0040012, GO:0051239, GO:0043535, GO:0051270, GO:2000145, GO:0008150, GO:2000147, GO:0048518, GO:0065007, GO:0032879, GO:0050794, GO:0050789, GO:0048522
GO:0045727 [BP]	positive regulation of translation	probable	GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:0031323, GO:0050789, GO:0080090, GO:0010604, GO:0010608, GO:0009891, GO:2000112, GO:0051247, GO:0051246, GO:0032270, GO:0048518, GO:0065007, GO:0010468, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0032268, GO:0010557, GO:0010556, GO:0006417, GO:0048522
GO:0016477 [BP]	cell migration	probable	GO:0040011, GO:0048870, GO:0009987, GO:0006928, GO:0051674, GO:0044763, GO:0008150, GO:0051179, GO:0044699
GO:0006954 [BP]	inflammatory response	probable	GO:0006952, GO:0050896, GO:0006950, GO:0008150, GO:0009611
GO:0051918 [BP]	negative regulation of fibrinolysis	probable	GO:0050820, GO:0050818, GO:0051240, GO:0032101, GO:0048583, GO:1900046, GO:0080134, GO:0051917, GO:0061041, GO:0065007, GO:0008150, GO:0051239, GO:0048518, GO:0030193, GO:0048519, GO:1900048, GO:0050789, GO:0030194
GO:0043652 [BP]	engulfment of apoptotic cell	probable	GO:0009987, GO:0006909, GO:0016192, GO:0016044, GO:0071840, GO:0006810, GO:0010324, GO:0006911, GO:0008150, GO:0061024, GO:0044765, GO:0044763, GO:0016043, GO:0043277, GO:0006897, GO:0051234, GO:0051179, GO:0044699
GO:0001953 [BP]	negative regulation of cell-matrix adhesion	probable	GO:0010810, GO:0030155, GO:0001952, GO:0050794, GO:0050789, GO:0007162, GO:0065007, GO:0008150, GO:0048519, GO:0010812, GO:0048523
GO:0045766 [BP]	positive regulation of angiogenesis	probable	GO:0022603, GO:0050793, GO:0051094, GO:0045765, GO:0008150, GO:1901342, GO:2000026, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0032695 [BP]	negative regulation of interleukin-12 production	probable	GO:0032655, GO:0051241, GO:0008150, GO:0001817, GO:0065007, GO:0051239, GO:0048519, GO:0050789, GO:0001818
GO:0006917 [BP]	induction of apoptosis	probable	GO:0050789, GO:0043067, GO:0050794, GO:0043065, GO:0048518, GO:0012502, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0050921 [BP]	positive regulation of chemotaxis	probable	GO:0040012, GO:0032103, GO:0040017, GO:0032101, GO:0048584, GO:0048583, GO:0050795, GO:0050789, GO:0008150, GO:0050920, GO:0048518, GO:0065007, GO:0048520
GO:0051897 [BP]	positive regulation of protein kinase B signaling cascade	probable	GO:0023051, GO:0009966, GO:0010740, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0050789, GO:0065007, GO:0009967, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0010627, GO:0051896, GO:0048522
GO:0030511 [BP]	positive regulation of transforming growth factor beta receptor signaling pathway	probable	GO:0090287, GO:0090100, GO:0009966, GO:0009967, GO:0048584, GO:0017015, GO:0090092, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0002581 [BP]	negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II	probable	GO:0002578, GO:0002577, GO:0002580, GO:0008150, GO:0065007, GO:0002682, GO:0002683, GO:0048519, GO:0050789
GO:0051592 [BP]	response to calcium ion	probable	GO:0042221, GO:0050896, GO:0010035, GO:0008150, GO:0010038
GO:0040037 [BP]	negative regulation of fibroblast growth factor receptor signaling pathway	probable	GO:0090287, GO:0009968, GO:0008150, GO:0009966, GO:0048585, GO:0048583, GO:0090288, GO:0050794, GO:0050789, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0010646, GO:0040036, GO:0048523
GO:0030169 [MF]	low-density lipoprotein particle binding	probable	GO:0071813, GO:0003674, GO:0071814, GO:0005488
GO:0043032 [BP]	positive regulation of macrophage activation	probable	GO:0050865, GO:0050867, GO:0050794, GO:0008150, GO:0002694, GO:0002684, GO:0002696, GO:0002682, GO:0048518, GO:0065007, GO:0043030, GO:0050789, GO:0048522
GO:0048471 [CC]	perinuclear region of cytoplasm	probable	GO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0065008 [BP]	regulation of biological quality	probable	GO:0008150, GO:0065007
GO:0002040 [BP]	sprouting angiogenesis	probable	GO:0032502, GO:0032501, GO:0009653, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0044699, GO:0048731, GO:0008150, GO:0001525, GO:0007275, GO:0048646
GO:0001968 [MF]	fibronectin binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0043499 [MF]	eukaryotic cell surface binding	probable
GO:0044087 [BP]	regulation of cellular component biogenesis	probable	GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0000187 [BP]	activation of MAPK activity	probable	GO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0048584, GO:0048583, GO:0032147, GO:0023056, GO:0043406, GO:0043405, GO:0023051, GO:0071902, GO:0010647, GO:0071900, GO:0010627, GO:0050789, GO:0043085, GO:0043408, GO:0010646, GO:0051347, GO:0010604, GO:0009966, GO:0009967, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0010740, GO:0050790, GO:0045937, GO:0060255, GO:0031323, GO:0045859, GO:0080090, GO:0050794, GO:0043410, GO:0032268, GO:0008150, GO:0042325, GO:0051174, GO:0042327, GO:0045860, GO:0031401, GO:0051338, GO:0001932, GO:0001934, GO:0048522
GO:0010748 [BP]	negative regulation of plasma membrane long-chain fatty acid transport	probable	GO:0051049, GO:0034765, GO:0034766, GO:0044070, GO:0050789, GO:0034762, GO:0034763, GO:0065007, GO:0043269, GO:0048519, GO:0010746, GO:2000192, GO:0051051, GO:2000191, GO:0050794, GO:0043271, GO:0008150, GO:0032890, GO:0032891, GO:0032879, GO:0032368, GO:0032369, GO:0048523
GO:0005178 [MF]	integrin binding	probable	GO:0032403, GO:0005102, GO:0003674, GO:0005488, GO:0005515
GO:0005577 [CC]	fibrinogen complex	probable	GO:0043234, GO:0032991, GO:0005615, GO:0005575, GO:0005576, GO:0044421

Prediction of Enzyme Commission Number

No confident prediction of EC number!

Spatial Structural Prediction